Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The Fenway Institute: Transgender People Who Access Gender-Affirming Hormones During Adolescence Less Likely to Experience Psychological Distress or Suicidal Ideation

The study adds important new knowledge to the evolving field of transgender health care


News provided by

Fenway Health

Jan 12, 2022, 17:30 ET

Share this article

Share toX

Share this article

Share toX


BOSTON, Jan. 12, 2022 /PRNewswire-PRWeb/ -- A study published in PLOS One found that access to gender-affirming hormones during adolescence is associated with better mental health outcomes among transgender adults. It is the first large-scale controlled study of gender-affirming hormone initiation during adolescence, the first study to compare access to gender-affirming hormones during adolescence versus adulthood, and adds important new knowledge to the evolving field of transgender health care.

"These results argue against waiting until adulthood to offer gender-affirming hormones to transgender adolescents and suggest that doing so may put patients at greater mental health risk," said senior study author Dr. Alex S. Keuroghlian, who directs the National LGBTQIA+ Health Education Center at The Fenway Institute and the Massachusetts General Hospital Psychiatry Gender Identity Program. "They also add to the growing evidence base suggesting that legislation restricting transgender adolescents' access to gender-affirming medical care would result in adverse mental health outcomes."

These results argue against waiting until adulthood to offer gender-affirming hormones to transgender adolescents and suggest that doing so may put patients at greater mental health risk.

Post this

The study, titled "Access To Gender-Affirming Hormones During Adolescence and Mental Health Outcomes Among Transgender Adults," compared past-month severe psychological distress and past-year suicidal ideation of 12,738 transgender adults who had accessed gender-affirming hormones during early adolescence, late adolescence, or adulthood with those of 8,860 transgender adults who desired gender-affirming hormones but had never accessed them. Among participants who accessed gender-affirming hormones during early adolescence (age 14-15), it found that the odds of severe psychological distress were decreased 222 percent and the odds of past-year suicidal ideation were decreased 135 percent. Among those who accessed gender-affirming hormones during late adolescence (age 16-17), odds of severe psychological distress and past-year suicide ideation were decreased by 153 percent and 62 percent, respectively. Compared to adults who desired but never accessed gender-affirming hormones, odds of decreased severe psychological distress and past-year suicide ideation among those who first accessed gender-affirming hormones during adulthood were 81 percent and 21 percent, respectively.

Other important findings from the study include the following:

  • A large proportion of transgender people desire but never access gender-affirming hormones. In this study, 41 percent of those who desired gender-affirming hormones were unable to access them.
  • Although odds of past-year suicidal ideation were significantly lower among those who accessed gender-affirming hormones during adolescence or adulthood, rates of past-year suicidal ideation were still high—as compared to the general population—even among study participants who reported having access to gender-affirming hormones. This finding suggests that other psychosocial stressors experienced by transgender people, such as employment discrimination, lack of access to public facilities, and acts of bias-motivated harassment and violence, contribute to chronic minority stress, which negatively affects health outcomes.
  • Those who first accessed gender-affirming hormones during adulthood were more likely to report past-month binge drinking and lifetime illicit drug use than those who reported desiring but never accessing gender-affirming hormones. This finding is partly explained by the fact that transgender people often become more socially engaged following the increased confidence that comes along with gender affirmation. But these results, along with the higher prevalence of substance use disorders among transgender people, support the need for routine screening for substance use and the development of culturally responsive substance use disorder prevention and treatment interventions.

"This study highlights that the U.S. has failed to make gender-affirming medical care accessible," said lead study author Dr. Jack Turban, Chief Fellow in Child & Adolescent Psychiatry at the Stanford University School of Medicine. "We urgently need to work on training more clinicians and combatting insurance discrimination."

Turban also cautioned that "lack of access to gender-affirming medical care could drive the use of non-prescribed gender-affirming hormones through the purchase of hormones online or on the black market without medical monitoring, which may lead to adverse physical health outcomes."

"Access To Gender-Affirming Hormones During Adolescence and Mental Health Outcomes Among Transgender Adults" is based on data from the 2015 U.S. Transgender Survey conducted by the National Center for Transgender Equality which surveyed over 27,000 transgender people in all 50 states, Washington D.C., Puerto Rico, U.S. territories abroad, and U.S. military bases on a multitude of questions about their lives. The paper is the latest in a series of secondary analyses of the groundbreaking 2015 survey evaluating factors that affect the mental health outcomes of transgender and gender diverse people. Prior papers include "Factors Leading to 'Detransition' Among Transgender and Gender Diverse People in the United States: A Mixed-Methods Analysis," published in 2021 in LGBT Health, "Association Between Gender-Affirming Surgeries and Mental Health Outcomes," published in 2021 in JAMA Surgery, "Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation," published in 2020 in Pediatrics, and "Association Between Recalled Exposure to Gender Identity Conversion Efforts and Suicide Attempts," published in 2020 in JAMA Psychiatry.

"Access To Gender-Affirming Hormones During Adolescence and Mental Health Outcomes Among Transgender Adults" was authored by researchers affiliated with the Division of Child & Adolescent Psychiatry, Stanford University School of Medicine, the Department of Psychiatry, Massachusetts General Hospital, The Fenway Institute at Fenway Health, the Department of Psychiatry, Harvard Medical School, the Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, the Department of Medicine, Harvard Medical School, and the Department of Epidemiology, Harvard T.H. Chan School of Public Health.

"Access To Gender-Affirming Hormones During Adolescence and Mental Health Outcomes Among Transgender Adults" is available online.

Media Contact

Christopher Viveiros, Fenway Health, 6177217494, [email protected]

Twitter

SOURCE Fenway Health

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.